MedicarePartD.guide

A non-government resource built from CMS public data

Tremfya on AARP Medicare Rx Preferred from UHC (S5921-385)

guselkumab

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 2 per 56 days.

$4,769.93
Patient pays / month, after deductible
$4,859.63
Patient pays / month, before the $130.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

TREMFYA 100 mg/mL Injection at a preferred retail pharmacy, from the plan's negotiated price of $15,386.88 for a month. Other covered strengths are listed below.

Prior authRequired on all 5 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 5 covered strengths and forms
FormTierPatient pays / monthLimits
TREMFYA 100 mg/mL Injection5$4,771.53PA · 2 per 56 days
TREMFYA 100 mg/mL Injection5$4,769.93PA · 2 per 56 days
TREMFYA 200 mg/2mL Injection5$4,943.06PA · 2 per 28 days
TREMFYA 200 mg/2mL Injection531%PA
TREMFYA 200 mg/2mL Injection5$4,943.06PA · 2 per 28 days

Other IL-17 and IL-23 biologics on this plan

Verify with the plan before prescribing or filling. Member services: (866)870-3470. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5921-385